Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant

References

• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–247. doi:10.1038/35041687
   PubMed Web of Science ®Google Scholar
• Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39(1):73–82. doi:10.1080/01616412.2016.1251711
   PubMed Web of Science ®Google Scholar
• Scandalios JG. Genomic responses to oxidative stress. Mol Cell Biol Mol Med. 2006;489–512.
   Google Scholar
• Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17(10):1195–1214. doi:10.1096/fj.02-0752rev
   PubMed Web of Science ®Google Scholar
• Chakravarti B, Chakravarti DN. Oxidative modification of proteins: age-related changes. Gerontology. 2007;53(3):128–139. doi:10.1159/000097865
   PubMed Web of Science ®Google Scholar
• Ballatore C, Huryn DM, Smith AB 3rd. Carboxylic acid (bio)isosteres in drug design. ChemMedChem. 2013;8(3):385–395. doi:10.1002/cmdc.201200585
   PubMed Web of Science ®Google Scholar
• Murphy MP. Targeting lipophilic cations to mitochondria. Biochim Biophys Acta. 2008;1777(7–8):1028–1031. doi:10.1016/j.bbabio.2008.03.029
   PubMed Web of Science ®Google Scholar
• Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med. 2011;11(57):106–114.
   PubMed Web of Science ®Google Scholar
• Amorim R, Benfeito S, Teixeira J, Cagide F, Oliveira PJ, Borges F. Targeting mitochondria: the road to mitochondriotropic antioxidants and beyond. Mitochondrial Biol Exp Ther. 2018;333–358.
   Google Scholar
• Teixeira J, Cagide F, Benfeito S, et al. Development of a mitochondriotropic antioxidant based on caffeic acid: proof of concept on cellular and mitochondrial oxidative stress models. J Med Chem. 2017;60(16):7084–7098. doi:10.1021/acs.jmedchem.7b00741
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1–3):3–26. doi:10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Benfeito S, Oliveira C, Fernandes C, et al. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction. Eur J Med Chem. 2019;167:525–545. doi:10.1016/j.ejmech.2019.01.055
   Web of Science ®Google Scholar
• Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2007;47(1):629–656. doi:10.1146/annurev.pharmtox.47.120505.105110
   PubMed Web of Science ®Google Scholar
• Teixeira J, Oliveira C, Amorim R, et al. Development of hydroxybenzoic-based platforms as a solution to deliver dietary antioxidants to mitochondria. Sci Rep. 2017;7(1):6842. doi:10.1038/s41598-017-07272-y
   Web of Science ®Google Scholar
• Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res. 2011;28(5):962–977. doi:10.1007/s11095-010-0303-7
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH. Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization. Elsevier Science; 2015.
   Google Scholar
• Seydel JK. Drug-membrane interaction and pharmacokinetics of drugs. Drug Membrane Interact. 2003;141–215.
   Google Scholar
• Pignatello R, Musumeci T, Basile L, Carbone C, Puglisi G. Biomembrane models and drug-biomembrane interaction studies: involvement in drug design and development. J Pharm Bioallied Sci. 2011;3(1):4–14. doi:10.4103/0975-7406.76461
   PubMedGoogle Scholar
• Lucio M, Lima JL, Reis S. Drug-membrane interactions: significance for medicinal chemistry. Curr Med Chem. 2010;17(17):1795–1809. doi:10.2174/092986710791111233
   Web of Science ®Google Scholar
• Stefaniu C, Brezesinski G, Mohwald H. Langmuir monolayers as models to study processes at membrane surfaces. Adv Colloid Interface Sci. 2014;208:197–213. doi:10.1016/j.cis.2014.02.013
   Web of Science ®Google Scholar
• Fernandes E, Soares TB, Goncalves H, et al. A molecular biophysical approach to diclofenac topical gastrointestinal damage. Int J Mol Sci. 2018;19(11):3411. doi:10.3390/ijms19113411
   Web of Science ®Google Scholar
• Lúcio M, Bringezu F, Reis S, Lima JLFC, Brezesinski G. Binding of nonsteroidal anti-inflammatory drugs to DPPC: structure and thermodynamic aspects. Langmuir. 2008;24(8):4132–4139. doi:10.1021/la703584s
   Web of Science ®Google Scholar
• Lucio M, Ferreira H, Lima FC, Reis S. Interactions between oxicams and membrane bilayers: an explanation for their different COX selectivity. Med Chem (Los Angeles). 2006;2(5):447–456. doi:10.2174/157340606778250199
   Google Scholar
• Lúcio M, Ferreira H, Lima JLFC, Reis S. Use of liposomes as membrane models to evaluate the contribution of drug–membrane interactions to antioxidant properties of etodolac. Redox Rep. 2013;13(5):225–236. doi:10.1179/135100008X308939
   Web of Science ®Google Scholar
• Lúcio M, Ferreira H, Lima JLFC, Reis S. Use of liposomes to evaluate the role of membrane interactions on antioxidant activity. Anal Chim Acta. 2007;597(1):163–170. doi:10.1016/j.aca.2007.06.039
   Web of Science ®Google Scholar
• Nunes C, Brezesinski G, Lima JL, Reis S, Lucio M. Synchrotron SAXS and WAXS study of the interactions of NSAIDs with lipid membranes. J Phys Chem B. 2011;115(24):8024–8032. doi:10.1021/jp2025158
   Web of Science ®Google Scholar
• Nunes C, Brezesinski G, Pereira-Leite C, Lima JL, Reis S, Lucio M. NSAIDs interactions with membranes: a biophysical approach. Langmuir. 2011;27(17):10847–10858. doi:10.1021/la201600y
   PubMed Web of Science ®Google Scholar
• Nunes C, Brezesinski G, Lopes D, Lima JLFC, Reis S, Lúcio M. Lipid–drug interaction: biophysical effects of tolmetin on membrane mimetic systems of different dimensionality. J Phys Chem B. 2011;115(43):12615–12623. doi:10.1021/jp206013z
   Web of Science ®Google Scholar
• Bailey-Hytholt CM, Shen TL, Nie B, Tripathi A, Shukla A. Placental trophoblast-inspired lipid bilayers for cell-free investigation of molecular interactions. ACS Appl Mater Interfaces. 2020;12(28):31099–31111. doi:10.1021/acsami.0c06197
   Web of Science ®Google Scholar
• Uehara TM, Marangoni VS, Pasquale N, Miranda PB, Lee KB, Zucolotto V. A detailed investigation on the interactions between magnetic nanoparticles and cell membrane models. ACS Appl Mater Interfaces. 2013;5(24):13063–13068. doi:10.1021/am404042r
   Web of Science ®Google Scholar
• Khadka Nawal K, Cheng X, Ho Chian S, Katsaras J, Pan J. Interactions of the anticancer drug tamoxifen with lipid membranes. Biophys J. 2015;108(10):2492–2501. doi:10.1016/j.bpj.2015.04.010
   Web of Science ®Google Scholar
• Sarpietro MG, Accolla ML, Santoro N, et al. Calorimetry and Langmuir–Blodgett studies on the interaction of a lipophilic prodrug of LHRH with biomembrane models. J Colloid Interface Sci. 2014;421:122–131. doi:10.1016/j.jcis.2014.01.040
   Web of Science ®Google Scholar
• Peetla C, Stine A, Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm. 2009;6(5):1264–1276. doi:10.1021/mp9000662
   PubMed Web of Science ®Google Scholar
• Fernandes E, Soares TB, Goncalves H, Lucio M. Spectroscopic studies as a toolbox for biophysical and chemical characterization of lipid-based nanotherapeutics. Front Chem. 2018;6:323. doi:10.3389/fchem.2018.00323
   Web of Science ®Google Scholar
• Seddon AM, Casey D, Law RV, Gee A, Templer RH, Ces O. Drug interactions with lipid membranes. Chem Soc Rev. 2009;38(9):2509. doi:10.1039/b813853m
   Web of Science ®Google Scholar
• Bunea A-I, Harloff-Helleberg S, Taboryski R, Nielsen HM. Membrane interactions in drug delivery: model cell membranes and orthogonal techniques. Adv Colloid Interface Sci. 2020;281:281. doi:10.1016/j.cis.2020.102177
   Web of Science ®Google Scholar
• Jelinek R, Kolusheva S. Membrane interactions of host-defense peptides studied in model systems. Curr Protein Pept Sci. 2005;6(1):103–114. doi:10.2174/1389203053027511
   Web of Science ®Google Scholar
• Nunes C, Sousa CT, Proença MP, et al. Synchrotron small angle X-ray scattering for the evaluation of the interaction of silica nanotubes with lipid membranes. RSC Adv. 2013;3(26):10323. doi:10.1039/c3ra22974b
   Web of Science ®Google Scholar
• Wang S, Guo H, Li Y, Li X. Penetration of nanoparticles across a lipid bilayer: effects of particle stiffness and surface hydrophobicity. Nanoscale. 2019;11(9):4025–4034. doi:10.1039/C8NR09381D
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Martins AF, Lucio M, et al. Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity? Toxicol in Vitro. 2011;25(6):1215–1223. doi:10.1016/j.tiv.2011.05.014
   Web of Science ®Google Scholar
• Hu X, Tam K. Biomembrane mimics and their roles in anti-bacterial drug discovery. ADMET DMPK. 2017;5(1):9. doi:10.5599/admet.5.1.375
   Google Scholar
• Sarkis J, Vie V. Biomimetic models to investigate membrane biophysics affecting lipid-protein interaction. Front Bioeng Biotechnol. 2020;8:270. doi:10.3389/fbioe.2020.00270
   Web of Science ®Google Scholar
• Jojart B, Posa M, Fiser B, Szori M, Farkas Z, Viskolcz B. Mixed micelles of sodium cholate and sodium dodecylsulphate 1:1 binary mixture at different temperatures–experimental and theoretical investigations. PLoS One. 2014;9(7):e102114. doi:10.1371/journal.pone.0102114
   Web of Science ®Google Scholar
• Magalhaes LM, Nunes C, Lucio M, Segundo MA, Reis S, Lima JL. High-throughput microplate assay for the determination of drug partition coefficients. Nat Protoc. 2010;5(11):1823–1830. doi:10.1038/nprot.2010.137
   Web of Science ®Google Scholar
• Lakowicz JR. Principles of Fluorescence Spectroscopy. 3 ed. Springer US; 2006.
   Google Scholar
• Musteata FM. Clinical utility of free drug monitoring. Ther Drug Monit. 2012;75–101.
   Google Scholar
• Rahnama E, Mahmoodian-Moghaddam M, Khorsand-Ahmadi S, Saberi MR, Chamani J. Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: a comparison study. J Biomol Struct Dyn. 2015;33(3):513–533. doi:10.1080/07391102.2014.893540
   PubMed Web of Science ®Google Scholar
• Carvalho AM, Fernandes E, Goncalves H, et al. Prediction of paclitaxel pharmacokinetic based on in vitro studies: interaction with membrane models and human serum albumin. Int J Pharm. 2020;580:119222. doi:10.1016/j.ijpharm.2020.119222
   Web of Science ®Google Scholar
• Seydel JK, Wiese M. Drug-Membrane Interactions Analysis, Drug Distribution, Modeling. Vol. 5. Weinheim: Wiley-VCH; 2002.
   Google Scholar
• van de Waterbeemd H, Kansy M. Hydrogen-bonding capacity and brain penetration. CHIMIA Int J Chem. 1992;46(7–8):299–303.
   Web of Science ®Google Scholar
• Liu X, Tu M, Kelly RS, Chen C, Smith BJ. Development of a computational approach to predict blood-brain barrier permeability. Drug Metab Dispos. 2004;32(1):132–139. doi:10.1124/dmd.32.1.132
   PubMed Web of Science ®Google Scholar
• Korzekwa K, Nagar S. Drug distribution part 2. predicting volume of distribution from plasma protein binding and membrane partitioning. Pharm Res. 2017;34(3):544–551. doi:10.1007/s11095-016-2086-y
   Web of Science ®Google Scholar
• Lombardo F, Obach RS, Shalaeva MY, Gao F. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. J Med Chem. 2002;45(13):2867–2876. doi:10.1021/jm0200409
   PubMed Web of Science ®Google Scholar
• Waters LJ, Shokry DS, Parkes GM. Predicting human intestinal absorption in the presence of bile salt with micellar liquid chromatography. Biomed Chromatogr. 2016;30(10):1618–1624. doi:10.1002/bmc.3731
   Web of Science ®Google Scholar
• Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci. 1999;88(8):807–814. doi:10.1021/js9804011
   PubMed Web of Science ®Google Scholar
• Kramer SD. Absorption prediction from physicochemical parameters. Pharm Sci Technolo Today. 1999;2(9):373–380. doi:10.1016/S1461-5347(99)00188-1
   Google Scholar
• Camenisch G, Alsenz J, Waterbeemd Hvd FG, Folkers G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. Eur J Pharm Sci. 1998;6(4):313–319. doi:10.1016/S0928-0987(97)10019-7
   Web of Science ®Google Scholar
• Katayama K, Fujita T. Studies on lymphatic absorption of 1ʹ,2ʹ-(3 H)-coenzyme Q 10 in rats. Chem Pharm Bull (Tokyo). 1972;20(12):2585–2592. doi:10.1248/cpb.20.2585
   PubMed Web of Science ®Google Scholar
• Zaki NM. Strategies for oral delivery and mitochondrial targeting of CoQ10. Drug Deliv. 2016;23(6):1868–1881. doi:10.3109/10717544.2014.993747
   PubMed Web of Science ®Google Scholar
• Lambrinidis G, Vallianatou T, Tsantili-Kakoulidou A. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review. Adv Drug Deliv Rev. 2015;86:27–45.
   PubMed Web of Science ®Google Scholar
• Wan H, Holmen A. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery. Comb Chem High Throughput Screen. 2009;12(3):315–329. doi:10.2174/138620709787581701
   PubMed Web of Science ®Google Scholar
• Naik KM, Kolli DB, Nandibewoor ST. Elucidation of binding mechanism of hydroxyurea on serum albumins by different spectroscopic studies. Springerplus. 2014;3(1):360. doi:10.1186/2193-1801-3-360
   Google Scholar
• Shamsi A, Ahmed A, Bano B. Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight. J Biomol Struct Dyn. 2018;36(6):1479–1489. doi:10.1080/07391102.2017.1326320
   PubMed Web of Science ®Google Scholar
• Shamsi A, Ahmed A, Khan MS, Husain FM, Bano B. Rosmarinic acid restrains protein glycation and aggregation in human serum albumin: multi spectroscopic and microscopic insight - possible therapeutics targeting diseases. Int J Biol Macromol. 2020;161(161):187–193. doi:10.1016/j.ijbiomac.2020.06.048
   Web of Science ®Google Scholar
• Shamsi A, Ahmed A, Khan MS, Al Shahwan M, Husain FM, Bano B. Understanding the binding between rosmarinic acid and serum albumin: in vitro and in silico insight. J Mol Liq. 2020;311(311):113348. doi:10.1016/j.molliq.2020.113348
   Web of Science ®Google Scholar
• Precupas A, Sandu R, Leonties AR, Anghel D-F, Popa VT. Complex interaction of caffeic acid with bovine serum albumin: calorimetric, spectroscopic and molecular docking evidence. New J Chem. 2017;41(24):15003–15015. doi:10.1039/C7NJ03410E
   Web of Science ®Google Scholar
• Hu YJ, Li W, Liu Y, Dong JX, Qu SS. Fluorometric investigation of the interaction between methylene blue and human serum albumin. J Pharm Biomed Anal. 2005;39(3–4):740–745. doi:10.1016/j.jpba.2005.04.009
   PubMed Web of Science ®Google Scholar
• Anwar S, Shamsi A, Kar RK, et al. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: towards therapeutic implications in neurodegenerative diseases. Int J Biol Macromol. 2020;161:596–604. doi:10.1016/j.ijbiomac.2020.06.078
   PubMed Web of Science ®Google Scholar
• Anwar S, Shamsi A, Shahbaaz M, et al. Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-65648-z.
   Web of Science ®Google Scholar
• Ross PD, Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 1981;20(11):3096–3102. doi:10.1021/bi00514a017
   PubMed Web of Science ®Google Scholar
• Satish L, Rana S, Arakha M, et al. Impact of imidazolium-based ionic liquids on the structure and stability of lysozyme. Spectrosc Lett. 2016;49(6):383–390. doi:10.1080/00387010.2016.1167089
   Web of Science ®Google Scholar
• Suvarna M, Dyawanapelly S, Kansara B, Dandekar P, Jain R. Understanding the stability of nanoparticle–protein interactions: effect of particle size on adsorption, conformation and thermodynamic properties of serum albumin proteins. ACS Appl Nano Mater. 2018;1(10):5524–5535. doi:10.1021/acsanm.8b01019
   Web of Science ®Google Scholar
• Yamasaki K, Chuang VT, Maruyama T, Otagiri M. Albumin-drug interaction and its clinical implication. Biochim Biophys Acta. 2013;1830(12):5435–5443. doi:10.1016/j.bbagen.2013.05.005
   PubMed Web of Science ®Google Scholar
• Li Y, Fawcett JP, Zhang H, Tucker IG. Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers. J Pharm Pharmacol. 2007;59(4):503–511. doi:10.1211/jpp.59.4.0004
   Web of Science ®Google Scholar
• Bemporad D, Essex JW, Luttmann C. Permeation of small molecules through a lipid bilayer: a computer simulation study. J Phys Chem B. 2004;108(15):4875–4884. doi:10.1021/jp035260s
   Web of Science ®Google Scholar
• van Balen GP, Martinet C, Caron G, et al. Liposome/water lipophilicity: methods, information content, and pharmaceutical applications. Med Res Rev. 2004;24(3):299–324. doi:10.1002/med.10063
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH. Profiling drug-like properties in discovery research. Curr Opin Chem Biol. 2003;7(3):402–408. doi:10.1016/S1367-5931(03)00055-3
   PubMed Web of Science ®Google Scholar
• Ballard P, Brassil P, Bui KH, et al. Metabolism and pharmacokinetic optimization strategies in drug discovery. Drug Des Devel. 2013;135–155.
   Google Scholar
• Greenblatt DJ, Abernethy DR, Divoll M. Is volume of distribution at steady state a meaningful kinetic variable? J Clin Pharmacol. 1983;23(8–9):391–400. doi:10.1002/j.1552-4604.1983.tb02753.x
   Web of Science ®Google Scholar
• Filler G. Extracorporeal therapies for poisoning. Compr Pediatr Nephrol. 2008;1045–1052.
   Google Scholar
• Saha S, Panieri E, Suzen S, Saso L. The interaction of flavonols with membrane components: potential effect on antioxidant activity. J Membr Biol. 2020;253(1):57–71. doi:10.1007/s00232-019-00105-1
   PubMed Web of Science ®Google Scholar
• Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct. 2004;33(1):269–295. doi:10.1146/annurev.biophys.32.110601.141803
   PubMedGoogle Scholar
• Poojari C, Wilkosz N, Lira RB, et al. Behavior of the DPH fluorescence probe in membranes perturbed by drugs. Chem Phys Lipids. 2019;223:104784. doi:10.1016/j.chemphyslip.2019.104784
   Web of Science ®Google Scholar
• Marsh D, Watts A, Knowles PF. Cooperativity of the phase transition in single- and multibilayer lipid vesicles. Biochim Biophys Acta Biomembr. 1977;465(3):500–514. doi:10.1016/0005-2736(77)9028-1
   Google Scholar
• Michel N, Fabiano AS, Polidori A, Jack R, Pucci B. Determination of phase transition temperatures of lipids by light scattering. Chem Phys Lipids. 2006;139(1):11–19. doi:10.1016/j.chemphyslip.2005.09.003
   Web of Science ®Google Scholar
• Domínguez A, Álvarez A, Hilario E, Suarez-Merino B, Goñi-de-Cerio F. Central nervous system diseases and the role of the blood-brain barrier in their treatment. Neurosci Discov. 2013;1(1):3. doi:10.7243/2052-6946-1-3
   Google Scholar
• Carpenter TS, Kirshner DA, Lau EY, Wong SE, Nilmeier JP, Lightstone FC. A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations. Biophys J. 2014;107(3):630–641. doi:10.1016/j.bpj.2014.06.024
   PubMed Web of Science ®Google Scholar
• Oliveira C, Bagetta D, Cagide F, et al. Benzoic acid-derived nitrones: a new class of potential acetylcholinesterase inhibitors and neuroprotective agents. Eur J Med Chem. 2019;174:116–129. doi:10.1016/j.ejmech.2019.04.026
   PubMed Web of Science ®Google Scholar
• Koynova R, Macdonald RC. Natural lipid extracts and biomembrane-mimicking lipid compositions are disposed to form nonlamellar phases, and they release DNA from lipoplexes most efficiently. Biochim Biophys Acta. 2007;1768(10):2373–2382. doi:10.1016/j.bbamem.2007.04.026
   PubMed Web of Science ®Google Scholar
• Ibarguren M, Lopez DJ, Escriba PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta. 2014;1838(6):1518–1528. doi:10.1016/j.bbamem.2013.12.021
   PubMed Web of Science ®Google Scholar
• Lopez S, Bermudez B. Membrane composition and dynamics: a target of bioactive virgin olive oil constituents. Biochim Biophys Acta. 2014;1838(6):1638–1656.
   PubMed Web of Science ®Google Scholar
• Hoekstra D, Martin OC. Transbilayer redistribution of phosphatidylethanolamine during fusion of phospholipid vesicles. Dependence on fusion rate, lipid phase separation, and formation of nonbilayer structures. Biochemistry. 1982;21(24):6097–6103. doi:10.1021/bi00267a011
   Web of Science ®Google Scholar
• Rappolt M, Hickel A, Bringezu F, Lohner K. Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution x-ray diffraction. Biophys J. 2003;84(5):3111–3122. doi:10.1016/S0006-3495(03)70036-8
   Web of Science ®Google Scholar
• Corazzi L, Roberti R. Lipids of brain mitochondria. Handbook Neurochem Mol Neurobiol. 2009;199–221.
   Google Scholar
• Carvalho C, Moreira PI. Oxidative stress: a major player in cerebrovascular alterations associated to neurodegenerative events. Front Physiol. 2018;9:806. doi:10.3389/fphys.2018.00806
   PubMed Web of Science ®Google Scholar